Vimarsana
Biggest News Aggregation in the World

Page 49 - David Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Ricks Today - Breaking & Trending Today

Pharmaceutical companies search for IRA response as they brace for drug pricing talks - Vimarsana News

Pharmaceutical companies search for IRA response as they brace for drug pricing talks

BioPharma

The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry - Vimarsana News

The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry

Eli Lilly is investing in hundreds of projects focused on AI, machine learning, and automation.

Source: yahoo.com
Related Topics:
Eli LillyDavid Ricks
Top Stories Wednesday, June 14: Deflation Pushes PPI To 28-Month Lows; Google's Dominance in Ad Tech Under European Scrutiny; Disney Delays Avatar, Marvel & Star Wars Release - Apple (NASDAQ:AAPL), Boeing (NYSE:BA) - Vimarsana News

Top Stories Wednesday, June 14: Deflation Pushes PPI To 28-Month Lows; Google's Dominance in Ad Tech Under European Scrutiny; Disney Delays Avatar, Marvel & Star Wars Release - Apple (NASDAQ:AAPL), Boeing (NYSE:BA)

Benzinga

Eli Lilly CEO Joins Other Pharma Execs, Raises Concern Over Medicare Price Negotiations Impacting Drug Development - Vimarsana News

Eli Lilly CEO Joins Other Pharma Execs, Raises Concern Over Medicare Price Negotiations Impacting Drug Development

Eli Lilly And Co (NYSE: LLY) CEO David Ricks voiced his concerns about the potential impact of Medicare price negotiations on drug development, which aim to reduce costs for older Americans. In an interview on CNBC's "The Exchange," Ricks said, "I'm really worried about the harm this will do to new cures and possibilities in medicine." Ricks specifically referred to a provision in the Inflation Reduction Act, proposed by the Biden administration, which empowers the Medicare program to negotiate

Source: yahoo.com
Eli Lilly CEO Joins Other Pharma Execs, Raises Concern Over Medicare Price Negotiations Impacting Drug Development - Eli Lilly (NYSE:LLY) - Vimarsana News

Eli Lilly CEO Joins Other Pharma Execs, Raises Concern Over Medicare Price Negotiations Impacting Drug Development - Eli Lilly (NYSE:LLY)

Eli Lilly And Co (NYSE: LLY) CEO David Ricks voiced his concerns about the potential impact of Medicare price negotiations on drug development, which aim to reduce costs for older Americans.